Search Results

1-12 of 12 results for subject:Methylphenidate

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Secretary of State for Health, how many NHS prescriptions for (a) Aricept, (b) Concerta XL and (c) Risperidone have been made in 2003; and what additional funds have been made available for prescription of these drugs. - Inc table.

Asked by

Tim Loughton (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

26 November 2003

For answer on

4 December 2003

Answered on

4 December 2003

Tim Loughton: To ask the Secretary of State for Health how many NHS prescriptions for (a) Aricept, (b) Concerta XL and (c) Risperidone have been made in 2003; and what additional funds have been made available for prescription of these drugs. [141071] Ms Rosie Winterton: Information on the number of prescription items and net ingredient cost (NIC) of all Aricept, Concerta and Risperidone drugs dispensed in the community in England in 2003 (January to September) is shown in the table. National health service bodies are expected to meet the costs of prescriptions from their unified allocations, which have increased on average by over 9 per cent., over the three years starting from 2002-03. Number of prescription items for Aricept, Concerts and Risperidone drugs dispensed in the community in England in 2003 (January to September 2003 only. Not a full year) _________________________________________________________________________________________________. Chemical name Items (000s) Donepezil Hydrochloride (Aricept) 181.3 Concerta 93.6 Risperidone (Risperdal) 1,019.6 _________________________________________________________________________________________________. Notes: 1. Aricept is included in British National Formulary (BNF) Section 4.11 (Drugs for dementia), and is a brand of the chemical entity Donepezil Hydrochloride. Aricept is the only brand. There are no generics available. Concerta is included in BNF Section 4.4 (Central nervous system stimulants), and is a brand of the chemical entity Methylphenidate Hydrochloride. Concerta is one of many brands of Methylphenidate Hydrochloride, including the generic. Risperidone is a chemical entity and is included in BNF Section 4.2 (Drugs used in psychoses and related disorders). Risperdal is the only brand of Risperdone, there are no generics available. 2. The data are based on prescription items dispensed in the community, ie by community pharmacists and appliance contractors, dispensing doctors, and prescriptions submitted by prescribing doctors for items personally administered in England. 3. The data do not cover drugs dispensed in hospital or private prescriptions. 4. Doctors, dentists or nurses write prescriptions on a prescription form. Each single item written on the form is counted as a prescription item. Source: Prescription Cost Analysis (PCA) data from the Prescription Pricing Authority

Date

4 December 2003

Reference

415 c178W; 141071

House

House of Commons

Home Office

To ask the Secretary of State for the Home Department, what research his Department has commissioned into ADD/ADHD in young offender institutions; what meetings have been held between his Department and the Departments for Health and Education and Skills on ADD/ADHD among inmates of young offender institutions; what steps his...

Asked by

Paul Burstow (Liberal Democrat)

Answering body

Home Office

Type

Written questions

Status

Answered

Tabled on

30 October 2003

For answer on

10 November 2003

Answered on

10 November 2003

Mr. Burstow: To ask the Secretary of State for the Home Department (1) what research his Department has commissioned into ADD/ADHD in young offender institutions; [136229] (2) what meetings have been held between his Department and the Departments for Health and Education and Skills on ADD/ADHD among inmates of young offender institutions; [136230] (3) what steps his Department has taken to assess the implications on behavioural difficulties of ADD/ ADHD in young people in young offender institutions; [136231] (4) how many young people were diagnosed with (a) ADD, (b) ADHD and prescribed Ritalin in (i) young offender institutions and (ii) secure training centres in each of the last five years. [136232] Paul Goggins: The Youth Justice Board (YJB) has commissioned Manchester University to undertake research at six sites, four of which are young offenders' institutions, into the prevalence of mental ill health, including Attention Deficit Hyper Activity Disorder (ADHD), and effective mental health practice. The YJB has developed a Mental Health Screening Tool and guidance on effective mental health practice. It is also developing a mental health awareness training pack for use by teams working with young people who come into contact with the criminal justice system. Officials in the Home Office and the Department of Health regularly discuss the whole range of health care issues in prisons and young offender institutions. The extent to which Attention Deficit Disorder (ADD)/ ADHD may be a significant problem in individual prison establishments would be expected to emerge from the regular health needs assessments undertaken jointly by prisons and their national health service partners. The Department of Health, the Prison Service and the YJB have created a new post of Programme Manager for Juvenile Health. This post will enable a greater focus on health issues such as ADD/ADHD, which are of potentially great significance in young offender institutions. The Government are investing significant additional resources, rising to around an extra £46 million in England by 2005-06, in prison health services over the next three years. Information is not collected centrally about the number of young people in young offenders' institutions and the juvenile secure estate who have been diagnosed with ADD/ ADHD or the particular treatments prescribed for them.

Date

10 November 2003

Reference

413 c91-2W; 136229;136230;136231;136232

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he plans to investigate the extent of methylphenidate prescribing in the UK. - Includes table and figures.

Asked by

Iris Robinson (Democratic Unionist Party)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

12 September 2003

For answer on

6 October 2003

Answered on

6 October 2003

Mrs. Iris Robinson: To ask the Secretary of State for Health if he plans to investigate the extent of Methylphenidate prescribing in the UK. [130259] Dr. Ladyman: Information is collected on the number of prescription items of all Methylphenidate drugs dispensed in the community. The data includes prescriptions prescribed in general practitioner practices, and prescriptions prescribed in hospitals that have been dispensed in the community. Private prescriptions, and prescriptions dispensed in hospitals are not included. Numbers of prescriptions in England for the years 1997 to 2002 are set out in the table. _________________________________________________________________________________________________. Items (Thousand) 1997 92.1 1998 126.6 1999 158.0 2000 186.2 2001 208.5 2002 254.0 _________________________________________________________________________________________________. In 2000, the National Institute for Clinical Excellence (NICE) made an appraisal of the use of Methylphenidate in the treatment of attention deficit hyperactivity disorder (ADHD). NICE estimated that approximately 1 per cent. of all school-aged children-- about 69,000 of 6 to 16-year-olds in England met the diagnostic criteria for Hyperkinetic Disorder, the more severe type ADHD, of whom some 45,000 might benefit from Methylphenidate were not receiving this treatment. A review of the appraisal is planned for this year.

Date

6 October 2003

Reference

130259; 410 c1320W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what the (a) short and (b) long-term adverse effects are described with methylphenidate.

Asked by

Iris Robinson (Democratic Unionist Party)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

6 October 2003

Reference

130260; 410 c1320-1W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many children have been prescribed methylphenidate in the last year. - Includes table.

Asked by

Paul Marsden (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

16 July 2003

For answer on

17 September 2003

Answered on

17 September 2003

Mr. Paul Marsden: To ask the Secretary of State for Health how many children have been prescribed methylphenidate in the last year. [127098] Dr. Ladyman: Information is not available in the form requested. However the figures in the following table show the total number of prescription items of Methylphenidate Hydrochloride dispensed in the community in England in each of the last five years. The majority of prescription items of Methylphenidate Hydrochloride are for the brand Ritalin. Number of prescription items of Methylphenidate Hydrochloride dispensed in the community in England. 1998 to 2002 Prescription items (thousand) _________________________________________________________________________________________________. Total 1998 126.6 1999 158.0 2000 186.2 2001 208.5 2001 254.0 _________________________________________________________________________________________________. Source: Prescription Cost Analysis data from the Prescription Pricing Authority In 2002, around 91 per cent. of the 254,000 prescription items were dispensed in the community to children (children under 16 and young people aged 16 to 18 in full time education). An estimated 1 per cent. of the items were dispensed to people aged 60 and over with the remainder being dispensed to other adults. These proportions have been similar in recent years.

Date

17 September 2003

Reference

127098; 410 c851W;410 c848-9W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what proportion of children prescribed methylphenidate for severe attention deficit hyperactivity disorder have been regularly monitored to assess improvement in the last year. - Inc list.

Asked by

Paul Marsden (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

8 September 2003

Reference

127096; 410 c218-9W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many people in each primary care trust aged up to 4 have been prescribed Riterlin in each of the last five years. - Inc ref to 8 July 2003, 408 c783-4W.

Asked by

Paul Burstow (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

14 July 2003

Reference

124236; 409 c126W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many people in each primary care trust aged (a) 0 to 15 years, (b) 16 to 59 and (c) 60 and over have been prescribed Ritalin in each of the last five years. - Including table and fact that information is...

Asked by

Paul Burstow (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

1 July 2003

For answer on

8 July 2003

Answered on

8 July 2003

Mr. Burstow: To ask the Secretary of State for Health how many people in each primary care trust aged (a) 0 to 15 years, (b) 16 to 59 and (c) 60 and over have been prescribed Ritalin in each of the last five years. [123766] Ms Rosie Winterton: Information is not available in the form requested. However the figures in the table show the total number of prescription items of Methylphenidate Hydrochloride dispensed in the community in England in each of the last five years. The majority of prescription items of Methylphenidate Hydrochloride are for the brand Ritalin. Number of prescription items of Methylphenidate Hydrochloride dispensed in the community in England--1998-2002 _________________________________________________________________________________________________. Year Thousands 1998 126.6 1999 158.0 2000 186.2 2001 208.5 2002 254.0 _________________________________________________________________________________________________. Source: Prescription cost analysis data from the Prescription Pricing Authority In 2002, around 91 per cent. of the 254,000 prescription items were dispensed in the community to children--children under 16 and young people aged 16 to 18 in full-time education. An estimated 1 per cent. of the items were dispensed to people aged 60 and over with the remainder being dispensed to other adults. These proportions have been similar in recent years.

Date

8 July 2003

Reference

123766; 408 c783-4W;408 c781W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what estimate he has made of the number of school children taking the drug Ritalin; and if he will make a statement. - Inc figure and fact that info not collected centrally on children.

Asked by

John Battle (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

28 April 2003

Reference

110187; 404 c252W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what assessment he has made of the level of prescribing of Ritalin to children diagnosed with manic depression.

Asked by

Paul Burstow (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

12 February 2003

Reference

96639; 399 c830W;399 c828W

House

House of Commons

Lords debate on unstarred question on what plans exist to reduce the impact of attention deficit disorder, attention deficit and hyperactivity disorder, and hypoglycaemia on said behaviour and academic performance

Lead member

Lord Hodgson of Astley Abbotts

Answering member

Baroness Andrews

Department

Department of Health

Type

Questions for short debate

Date

5 February 2003

Reference

644 c299-322

House

House of Lords

Deposited Paper DEP 03/254

Number of prescription items dispensed in the community in England for Methylphenidate Hydrochloride by Health Authorities and Regions 1999 to 2001.

Deposited by

Department of Health

Type

Deposited papers

Date

23 January 2003

Reference

DEP 03/254

House

House of Commons

Librarians' tools

Type

House

Session

Month

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher